Literature DB >> 2015045

Barrier cells in the spleen.

L Weiss1.   

Abstract

Barrier cells are a newly defined group of activated fibroblastic cells that are deployed as diverse barriers in the splenic pulp. The central capacity of the spleen, namely clearance of the blood, is normally modest but when stressed, for example by infectious disease, imperfect blood cells or the administration of interleukin 1, the clearance capacities of the spleen expand. The normally scarce barrier cells rapidly and greatly increase in number in splenic stress. By augmenting the splenic filtration beds, regulating blood flow, enveloping white pulp and enclosing hematopoietic colonies, they appear to be important in the spleen's increased capacities in clearance, phagocytosis, immunological reactivity and hematopoiesis. This review focuses on their role in the spleen, but barrier cells may appear throughout the body in response to needs for walling off and cellular induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015045     DOI: 10.1016/0167-5699(91)90108-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  13 in total

Review 1.  Spleen: A new role for an old player?

Authors:  Giovanni Tarantino; Silvia Savastano; Domenico Capone; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

2.  Description of a new population of fixed macrophages in the splenic cords of pigs.

Authors:  L Carrasco; M J Bautista; J Martin de las Mulas; J C Gómez-Villamandos; A Espinosa de los Monteros; M A Sierra
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

3.  Immunohistochemical organization patterns of the follicular dendritic cells, myofibroblasts and macrophages in the human spleen--new considerations on the pathological diagnosis of splenectomy pieces.

Authors:  Pablo Guisado Vasco; José L Villar Rodríguez; José Ibañez Martínez; Ricardo González Cámpora; Hugo Galera Davidson
Journal:  Int J Clin Exp Pathol       Date:  2009-12-10

4.  Supplementation of CXCL12 (CXCL12) induces homing of CD11c+ dendritic cells to the spleen and enhances control of Plasmodium berghei malaria in BALB/c mice.

Authors:  Margoth Ramos Garnica; Luciana Vieira de Moraes; Luiz Vicente Rizzo; Heitor Franco de Andrade
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 5.  Stromal cell contributions to the homeostasis and functionality of the immune system.

Authors:  Scott N Mueller; Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2009-07-31       Impact factor: 53.106

6.  Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.

Authors:  L L Lenz; E A Butz; M J Bevan
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

7.  Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria.

Authors:  Bridget E Barber; Timothy William; Matthew J Grigg; Uma Parameswaran; Kim A Piera; Ric N Price; Tsin W Yeo; Nicholas M Anstey
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

8.  Spleen-Dependent Immune Protection Elicited by CpG Adjuvanted Reticulocyte-Derived Exosomes from Malaria Infection Is Associated with Changes in T cell Subsets' Distribution.

Authors:  Lorena Martín-Jaular; Armando de Menezes-Neto; Marta Monguió-Tortajada; Aleix Elizalde-Torrent; Míriam Díaz-Varela; Carmen Fernández-Becerra; Francesc E Borras; Maria Montoya; Hernando A Del Portillo
Journal:  Front Cell Dev Biol       Date:  2016-11-16

9.  The Postembryonic Development of the Immunological Barrier in the Chicken Spleens.

Authors:  Qian Zhang; Xuejing Sun; Taozhi Wang; Bing Chen; Yufei Huang; Hong Chen; Qiusheng Chen
Journal:  J Immunol Res       Date:  2019-05-05       Impact factor: 4.818

10.  Augmented particle trapping and attenuated inflammation in the liver by protective vaccination against Plasmodium chabaudi malaria.

Authors:  Jürgen Krücken; Denis Delić; Heike Pauen; Anna Wojtalla; Manal El-Khadragy; Mohamed A Dkhil; Horst Mossmann; Frank Wunderlich
Journal:  Malar J       Date:  2009-04-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.